Theseus Pharmaceuticals (THRX) Cash Flow Annual - Discounting Cash Flows
Theseus Pharmaceuticals, Inc.
THRX (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing: 2023-03-09 2022-03-10 2020-12-31 2019-12-31
Net Income/Starting Line
-50.6 -27.3 -12.0 -7.18
Cash From Operating Activities
-32.9 -27.2 -4.85 -4.81
Depreciation and Amortization
0.05 0.00 0.00 0.00
Deferred Income Tax
0.00 -4.36 0.00 0.00
Stock Based Compensation
11.4 4.36 1.05 0.32
Other Non-Cash Items
-0.35 4.36 5.16 2.24
Changes in Working Capital
6.55 -4.25 0.93 -0.18
Accounts Receivable
0.00 0.00 0.00 0.00
Inventory
0.00 0.00 0.00 0.00
Accounts Payable
3.97 -0.15 0.85 0.19
Deferred Revenue
2.58 -4.10 0.08 -0.37
Other Working Capital
0.00 0.00 0.00 0.00
Cash From Investing Activities
-117 0.01 0.00 0.00
Investments in Property Plant and Equipment
-0.46 0.01 0.00 0.00
Payments for Acquisitions
0.12 0.00 0.00 0.00
Purchases of Securities
-191 0.00 0.00 0.00
Sales and Maturities of Investments
74.6 0.00 0.00 0.00
Other Investing Activities
-0.12 0.00 0.00 0.00
Cash From Financing Activities
0.00 264 12.0 2.99
Debt Repayment
0.00 0.00 0.00 0.00
Common Stock Issued
0.00 166 12.0 2.99
Common Stock Repurchased
0.00 0.00 0.00 0.00
Dividends Paid
0.00 0.00 0.00 0.00
Other Financing Activities
0.18 264 12.0 2.99
Effect of Forex Changes on Cash
0.00 -0.01 0.00 0.00
Net Change in Cash
-150 237 7.14 -1.81
Cash at Beginning of Period
245 8.46 1.32 3.13
Cash at End of Period
95.0 245 8.46 1.32
Free Cash Flow
-33.4 -27.2 -4.85 -4.81
Operating Cash Flow
-32.9 -27.2 -4.85 -4.81
Capital Expenditure
-0.46 0.01 0.00 0.00
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us